Investeringsoversigt

597 investments

Titel Sort descending	Periode	Program
Development of a first-of-a-kind complete solution for DNA methylation analysis	2019 - 2019	Innobooster
Development of a first-of-a-kind complete solution for DNA methylation analysis Period 2019 - 2019 Region Region Nordjylland Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 33 Invested 443.932 Budget 1.3 mill. Partners MethylDetect ApS People Methyl Detect ApS Read more about the project
Development of a long-acting dual GIP/GLP-2 tool compound for chronic PoC studies.	2019 - 2022	Industrial Researcher
Development of a long-acting dual GIP/GLP-2 tool compound for chronic PoC studies. Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 54.14 Invested 1.1 mill. Budget 2.0 mill. Partners University of Copenhagen, Bainan Biotech ApS People Bainan Biotech ApS Read more about the project
Development of a novel low-volume in vitro pig (LovInPig) gut model with increased throughput	2018 - 2021	Industrial Researcher
Development of a novel low-volume in vitro pig (LovInPig) gut model with increased throughput Period 2018 - 2021 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 65.13 Invested 1.3 mill. Budget 2.0 mill. Partners University of Copenhagen, Chr. Hansen A/S People Chr. Hansen A/S Read more about the project
Development of a Novel Platform for Screening Interactions with Human Serum Albumin	2017 - 2020	Industrial Researcher
Development of a Novel Platform for Screening Interactions with Human Serum Albumin Period 2017 - 2020 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 41.71 Invested 1.1 mill. Budget 2.6 mill. Partners Aarhus University, Novo Nordisk A/S People Novo Nordisk A/S Read more about the project
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery	2020 - 2023	Industrial Researcher
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.2 mill. Budget 1.2 mill. Partners University of Copenhagen, FluoGuide A/S People FluoGuide A/S Read more about the project
Development of a platform for isolation of circulating tumor cells to improve early cancer detection and diagnosis.	2017 - 2020	Industrial Researcher
Development of a platform for isolation of circulating tumor cells to improve early cancer detection and diagnosis. Period 2017 - 2020 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 22.79 Invested 1.1 mill. Budget 4.7 mill. Partners University of Copenhagen, VarCT Diagnostics ApS People VarCT Diagnostics ApS Read more about the project
Development of a Prophylactic Vaccine Against Hepatitis C Virus	2019 - 2020	Innoexplorer
Development of a Prophylactic Vaccine Against Hepatitis C Virus Period 2019 - 2020 Region Region Hovedstaden Program Innoexplorer Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.5 mill. Budget 1.5 mill. Partners HVIDOVRE HOSPITAL People HVIDOVRE HOSPITAL Read more about the project
Development of a sustainable fermentation process for high value lipoic acid	2018 - 2020	Innobooster
Development of a sustainable fermentation process for high value lipoic acid Period 2018 - 2020 Region Region Hovedstaden Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 32.9 Invested 4.8 mill. Budget 14.7 mill. Partners Biosyntia ApS People BIOSYNTIA ApS Read more about the project
Development of a therapeutic HER2 based vaccine against breast cancer	2019 - 2022	Industrial Researcher
Development of a therapeutic HER2 based vaccine against breast cancer Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 45.3 Invested 1.2 mill. Budget 2.7 mill. Partners University of Copenhagen, AdaptVac ApS People AdaptVac ApS Read more about the project
Development of a therapeutic vaccine targeting HER2 positive breast cancer	2019 - 2020	Innobooster
Development of a therapeutic vaccine targeting HER2 positive breast cancer Period 2019 - 2020 Region Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 33 Invested 808.500 Budget 2.5 mill. Partners AdaptVac People Aktiv Read more about the project
Development of a translational rat model of non-alcoholic steatohepatitis (NASH) with liver fibrosis	2021 - 2023	Industrial Researcher
Development of a translational rat model of non-alcoholic steatohepatitis (NASH) with liver fibrosis Period 2021 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.1 mill. Budget 1.1 mill. Partners University of Copenhagen, GUBRA ApS People GUBRA ApS Read more about the project
Development of an immune modulating cancer vaccine targeting CCL22	2020 - 2023	Industrial Researcher
Development of an immune modulating cancer vaccine targeting CCL22 Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 36.05 Invested 1.1 mill. Budget 3.0 mill. Partners University of Copenhagen, IO BIOTECH ApS People IO BIOTECH ApS Read more about the project
Development of Clinical Applications for Evosep One	2021 - 2023	Industrial Researcher
Development of Clinical Applications for Evosep One Period 2021 - 2023 Region Region Syddanmark Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.2 mill. Budget 1.2 mill. Partners University of Southern Denmark, Evosep ApS People Evosep ApS Read more about the project
Development of CRISPR-based drugs targeting MDR/XDR ‘high-risk clones’ of Pseudomonas aeruginosa	2020 - 2023	Industrial Researcher
Development of CRISPR-based drugs targeting MDR/XDR ‘high-risk clones’ of Pseudomonas aeruginosa Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 64.05 Invested 1.1 mill. Budget 1.7 mill. Partners Technical University of Denmark, SNIPR BIOME APS People SNIPR BIOME APS Read more about the project
Development of gastro-intestinal tract pre-clinical in vitro screening model for investigating CRISPR-mediated precision modulation of gut microbiomes (In vitro SNIPR)	2021 - 2023	Industrial Researcher
Development of gastro-intestinal tract pre-clinical in vitro screening model for investigating CRISPR-mediated precision modulation of gut microbiomes (In vitro SNIPR) Period 2021 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.1 mill. Budget 1.1 mill. Partners University of Copenhagen, SNIPR Biome ApS People SNIPR Biome ApS Read more about the project